Chemed (CHE) Other financing activities (2009 - 2026)

Chemed has reported Other financing activities for 18 years, with the latest figure at $1.4 million in Q2 2026.

• Other financing activities for Q2 2026 came in at $1.4 million, down 68.37% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.7 million (down 93.94% YoY), and the FY2025 annual result was $27.2 million, down 51.96% from the prior year.
• Other financing activities improved to $1.4 million in Q2 2026, from $1.3 million in the prior quarter.
• Over five years, Other financing activities peaked at $43.9 million in Q4 2023 and troughed at $1.3 million in Q1 2026.
• A 5-year average of $14.6 million and a median of $7.2 million in 2022 frame the typical range for Other financing activities.
• The widest annual swing landed in 2023, when Other financing activities jumped 440.76%; it then sank 95.17% in 2024.
• A 5-year view of Other financing activities shows it stood at $27.8 million in 2022, then jumped by 57.74% to $43.9 million in 2023, then slumped by 84.95% to $6.6 million in 2024, then sank by 32.14% to $4.5 million in 2025, then tumbled by 68.37% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $1.4 million in Q2 2026, $1.3 million in Q1 2026, and $4.5 million in Q2 2025.